Dr. West moderates a question & answer session with Drs. Karen Reckamp and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for patients with advanced NSCLC that harbors a driver mutation.

[powerpress]

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.